CervoMed Inc. (NASDAQ: CRVO) was downgraded by analysts at HC Wainwright from a "buy" rating to a "neutral" rating.
CervoMed Inc. (NASDAQ: CRVO) was downgraded by analysts at Brookline Capital Management from a "strong-buy" rating to a "hold" rating.
CervoMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CervoMed Inc. (NASDAQ: CRVO) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $65.00 to $12.00. They now have a "buy" rating on the stock.
CervoMed Inc. (NASDAQ: CRVO) had its "underweight" rating re-affirmed by analysts at Morgan Stanley.